Tata Consultancy Services has launched the ADD (Advanced Drug Development) size feasibility platform which provides life sciences companies with a single, integrated platform that digitises the site selection and activation processes, and facilitates data-driven decision-making while assessing site feasibility for multi-site clinical trials.

Many of us may have a retirement account with PFRDA. So investing Rs. 50,000 in NPS is enough to fund your retirement needs? Let’s figure it out.

Generally, D/E should be less than one as it lends financial stability. But there are capital intensive industries like infra, capital goods wherein D/E ratio remains at a higher level compared with the companies that operate in the FMCG and IT space which are like cash-generating machines.

Specialty pharmaceutical company, Unichem Laboratories informed the bourses that United States Food and Drug Administration (USFDA) has conducted a routine GMP surveillance at company’s Goa formulation facility. The company had submitted ANDAs from this facility.

India-based subsidiary of Dr. Reddy's, Aurigene has entered an exclusive collaboration agreement with the US-based oncology-focused biotech company Exelixis, Inc.

Overall volumes in futures & options currently stand at 2,27,94,937 contracts with a turnover of Rs. 15,25,426.99 crore.

Overall volumes in futures & options currently stand at 2,27,94,937 contracts with a turnover of Rs. 15,25,426.99 crore.

Dilip Buildcon has received the letter of acceptance (LoA) from the Ministry of Road Transport & Highways, New Delhi for a new EPC project in the state of Karnataka.

ZEE Entertainment Enterprise (ZEEL) on Wednesday announced the much-awaited stake sale deal. The Invesco Oppenheimer Developing Markets Fund has agreed to buy 11 per cent stake in ZEEL. 

Due to coal crunch, NTPC has shut down three of its units at its plant located in Kaniha in the state of Orissa.